DR. PHONE FIX ENTERS INTO NATIONAL REPAIR AGREEMENT WITH LIKEWIZE, A GLOBAL INSURANCE PROVIDER FOR DEVICE PROTECTION
TORONTO, June 18, 2025 /CNW/ - Dr. Phone Fix Canada Corporation ("Dr. Phone Fix" or "Company")(TSXV: DPF) announced today that it has entered into a national repair agreement with Likewize, a global leader in device protection and insurance, operating in over 30 countries. Dr. Phone Fix is recognized by the Financial Times as one of North America's fastest-growing companies, with 35 locations in 23 cities across four provinces.
Under the agreement, Canadians who are insured by Likewize and have a broken or damaged phone can now have it repaired at any Dr. Phone Fix store.
"Canadians break as many as 600 phones per hour, and when that happens, they're disconnected from banking, entertainment, communication, and more," said Dr. Phone Fix CEO, Piyush Sawhney. "If they've insured their device through Likewize, they can now have it repaired by any Dr. Phone Fix store near them — a Canadian industry leader known for fast, trustworthy, reliable service."
Likewize Canadian President, Ron Cihocki commented, "This agreement is an exciting step forward in our mission to make every tech problem painless. By adding Dr. Phone Fix locations to our repair network, we're making it easier and more convenient than ever for customers to get their phones fixed and back online."
Sawhney added, "In just six years since we opened our first store, we've repaired tens of thousands of devices and built a reputation we're proud of. More than 29,000 customers have left positive online reviews, praising our knowledgeable and friendly technicians, our strong parts supply chain, and our ability to complete most repairs in less than an hour."
About Likewize
Founded in 1997 and headquartered in Dallas, TX, Likewize operates in 30 countries and is trusted by many of the world's largest brands, including telecoms, financial institutions, and retailers. The company manages over 250 million device issues annually and provides a comprehensive range of services, including warranties, repairs, upgrades, and premium technical support.
For more information visit www.likewize.com
About Dr. Phone Fix
DPF is an award-winning, eco-friendly, customer-centric growth leader in Canada's cell phone and electronics repair and pre-owned resale industry. Founded in 2019, DPF operates a nationwide network of 35 corporately owned cell phone and electronics repair stores. In addition to its repair services, DPF sells certified pre-owned devices and a wide selection of accessories. DPF has well-established networks to acquire and resell a wide variety of used and refurbished electronic devices from certified vendors.
Dr. Phone Fix is traded on the TSX Venture Exchange under the symbol "DPF"
For more information visit www.docphonefix.com.
NEITHER THE TSXV NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSXV) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS NEWS RELEASE.
This news release does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction.
Cautionary Statement Regarding Forward-Looking Information
This news release contains "forward-looking information" within the meaning of applicable securities laws. Forward-looking information can be identified by words such as: "intend", "believe", "estimate", "expect", "may", "will" and similar references to future periods. Examples of forward-looking information include, among others, the future plans of the Company, the expected trading date of the Resulting Issuer Shares on the TSXV, as well as information relating to the Company. Although the Company believes that, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements depending on, among other things, the risks (i) that the future plans of the Company may differ from those that currently are contemplated; and (ii) that the expected trading date of the Resulting Issuer Shares may change. Additional risks include those disclosed in the Filing Statement, which are incorporated herein by reference and are available through SEDAR at www.sedar.com. The forward-looking statements contained in this news release are made as of the date hereof, and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, except as required by law.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Global News
26 minutes ago
- Global News
Doug Ford hands cabinet ministers mandate letters months after winning snap election
Months after winning a third consecutive majority mandate under a promise to 'protect Ontario' from economic war with the United States, Ontario Premier Doug Ford has outlined how he expects his inner circle to deliver the pledge. Multiple sources confirmed to Global News that mandate letters were finally delivered to cabinet ministers this week, giving each member of Ford's top team specific instructions. The wait for mandate letters meant ministers did not have codified instructions during the first sitting of the new parliament, leaving some smaller departments struggling with a lack of legislative direction. Ford's cabinet was sworn in in mid-March and, several sources told Global News, had hoped to use the summer to create policy road maps based on the mandate letters, which did not arrive. Sources previously said a combination of the snap February election, the federal ballot and staffing changes in the premier's policy team had all delayed the letters. Story continues below advertisement A spokesperson for the premier's office said the ongoing trade war with the United States is at the centre of the latest mandate letters. Get daily National news Get the day's top news, political, economic, and current affairs headlines, delivered to your inbox once a day. Sign up for daily National newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy 'As we navigate an economic crisis that threatens the livelihood of hundreds of thousands of workers, our mandate letters provide the roadmap for long-term implementation of our plan to protect Ontario,' they wrote in a statement. 'The people elected our government with a historic third majority, and we will be relentless in building critical infrastructure, keeping costs low, unlocking interprovincial free trade, supporting Ontario-made products, and cracking down on crime.' Previous mandate letters The mandate letters are a traditional moment in Canadian politics. Written by the head of a government to cabinet members, they lay out the aims and goals of their department. Until 2018, it was traditional for governments to use them as a public platform to signal intent. Story continues below advertisement When Ford took office, however, he opted not to make his mandate letters public. That resulted in a legal battle which went all the way to the Supreme Court, which last year sided with Ford and confirmed he could keep them secret. The 2018 letters, obtained exclusively by Global News, outlined the premier's vision for Ontario, how cabinet members were expected to conduct themselves, and specific policy measures ministries were expected to pursue. They offered a number of bullet-point policy items — some of which were outlined in the party's election platform, along with other policies never revealed to voters. Andrew Sidnell, who once served as Ford's deputy chief of staff and head of policy in the premier's office, told Ontario's Integrity Commissioner that not all the measures outlined in the mandate letter were acted on and that some could be dropped after internal negotiations. 'You go back and forth, and then some of those things eventually are either too ambitious or they get cut off the list for impracticality reasons. Or, they do move forward and the minister will come back with a plan to actually implement them,' Sidnell told the Integrity Commissioner. In 2022, for example, then-housing minister Steve Clark was instructed to look for 'swaps, expansions, contractions' in Ontario's Greenbelt — a directive that eventually led to a scandal for the government.
Toronto Star
26 minutes ago
- Toronto Star
ERES Declares August 2025 Monthly Distribution
TORONTO, Aug. 15, 2025 (GLOBE NEWSWIRE) — European Residential Real Estate Investment Trust (TSX: 'ERES') is pleased to announce that the trustees of ERES have declared the August 2025 monthly cash distribution of €0.005 per Unit and Class B LP Unit (the 'August 2025 Distribution'), being equivalent to €0.06 per Unit annualized. The distribution will be payable to holders of the Units and Class B LP Units (the 'Unitholders') of record on August 29, 2025, with payment on September 15, 2025. The Euro-denominated distribution will be paid in Canadian dollars based on the exchange rate on the date of payment (estimated C$0.00801 per Unit and Class B LP Unit). Registered Unitholders will be provided with an option to elect to receive such distribution in Euros rather than Canadian dollars. If no such election is made, registered Unitholders will be paid the distribution in Canadian dollars based on the above exchange rate mechanism. Beneficial Unitholders will not have an option to elect to receive the distribution in Euros. The final cash distribution in respect of July 2025 was C$0.00801 per Unit and Class B LP Unit.
Toronto Star
26 minutes ago
- Toronto Star
PharmaCorp Rx Inc. Reports Q2 2025 Financial Results
SASKATOON, Saskatchewan, Aug. 15, 2025 (GLOBE NEWSWIRE) — PHARMACORP RX INC. ('PharmaCorp' or the 'Corporation') (TSXV: PCRX) a growing national platform for pharmacist-led community pharmacy ownership, today reported its financial results for the three and six months ended June 30, 2025. The second quarter reflected continued operational momentum, expanding pharmacy-level contribution, and disciplined progress on the Corporation's national acquisition strategy. Following quarter-end, PharmaCorp completed the acquisition of a fourth pharmacy in Western Canada, building further scale and reinforcing the platform's coast-to-coast ambitions. Q2 2025 Financial Highlights Revenues generated from three operating pharmacies, with continued growth in both prescription volumes and front-of-store sales Operating infrastructure was successfully deployed to support national scalability, including systems integration, pharmacy onboarding, and co-ownership execution Net loss for the quarter reflects continued investment in corporate infrastructure and the catch-up of executive compensation deferred from 2024 Solid pharmacy-level contribution margins and a consistent weighted average EBITDA multiples across acquisitions support PharmaCorp's long-term accretive growth model A strong balance sheet positions the Corporation to fund additional acquisitions already under letter of intent Same-store sales, a supplementary financial measure, increased 11.3% year-over-year compared to Q2 2024, reflecting continued organic growth across our pharmacy network Prescription volumes continue to grow, with total script count rising 3.5% year-over-year compared to Q2 2024, demonstrating sustained patient engagement and activity across the network Management Commentary 'We are pleased with the momentum we're seeing across our early acquisitions and the continued appetite from independent pharmacy owners exploring succession,' said Alan Simpson, Executive Chairman of PharmaCorp. 'This quarter reflects continued progress in scaling our platform through disciplined execution. We continue to maintain a consistent, disciplined weighted average EBITDA multiple across our acquisitions, which supports our goal of delivering accretive growth. As we expand our national footprint, we remain focused on sourcing high-quality pharmacies that align with our long-term acquisition strategy and contribute meaningfully to accretion.' ARTICLE CONTINUES BELOW Operational Update During the quarter, the Corporation made key investments in systems, personnel, and integration processes necessary to support scalable national growth. The reported net loss includes compensation charges related to deferred 2024 executive remuneration, which were brought current in Q2 as part of aligning leadership incentives with long-term shareholder value. Subsequent Events On July 31, 2025, the Corporation closed the acquisition of its fourth pharmacy, located in Western Canada, further expanding its national footprint and operating base under the PharmaCorp co-ownership platform. On August 13, 2025, the Corporation entered into a credit agreement with Canadian Imperial Bank of Commerce ('CIBC') providing the Corporation with up to $20,500,000 of committed credit facilities (the 'Credit Facilities'), plus a $10,000,000 accordion feature and a $1,000,000 Visa credit facility. The Credit Facilities will support PharmaCorp's acquisition strategy and the expansion of its acquisition and operating platforms. In conjunction with the above Credit Facilities, CIBC is also supporting PharmaCorp's Pharmacist Co-Ownership Program through a separate $5,000,000 credit facility which makes loans available to pharmacists wishing to acquire an ownership position in the PharmaCorp pharmacy where they work. Pipeline Progress PharmaCorp continues to advance its previously announced pipeline of transactions. The Corporation is actively working to finalize definitive purchase and sale agreements in furtherance of the letters of intent announced on May 29, 2025, and expects to close additional transactions in the second half of the year. Further Information For comprehensive disclosure of PharmaCorp's financial performance for the three and six months ended June 30, 2025 and its financial position as at such date, please see PharmaCorp's unaudited Condensed Consolidated Interim Financial Statements and related Management's Discussion and Analysis for the three and six months ended June 30, 2025 filed on SEDAR+ at Supplementary Financial Measures This news release also makes reference to 'same-store sales', which is a supplementary financial measure. 'Same-store sales' is defined as sales from pharmacy locations owned and operated by PharmaCorp as at the current reporting period end and historical sales information from the pharmacies operating systems. It is used to provide investors with a supplemental measure of the Corporation's operating performance and thus highlight trends in its core business that may not otherwise be apparent when relying solely on IFRS financial measures. Management uses supplementary financial measures such as same-store sales in order to facilitate operating performance comparisons from period to period. Management also believes that supplementary financial measures are meaningful to investors because they enable investors to better understand the level of growth of our business. The Corporation cautions readers that same-store sales used in this news release may not be comparable to similar measures used by other issuers. ARTICLE CONTINUES BELOW ARTICLE CONTINUES BELOW About PharmaCorp Rx Inc. PharmaCorp Rx Inc. is a Canadian pharmacy acquisition and ownership platform focused on empowering pharmacists to become equity partners while supporting continuity of care and succession for retiring pharmacy owners. PharmaCorp combines operational support, capital, and strategic guidance to build a national network of locally rooted community pharmacies. PharmaCorp currently operates four PharmaChoice Canada bannered pharmacies in Canada and will continue to acquire PharmaChoice Canada branded pharmacies as they come to market in conjunction with its strategic alliance agreement with PharmaChoice Canada. The Corporation will also acquire independently owned non-PharmaChoice Canada bannered pharmacies in Canada, and thereafter, continue to operate such acquired pharmacies under a PharmaChoice Canada banner. PharmaCorp shares trade on the TSX Venture Exchange under the symbol: PCRX. PharmaCorp actively welcomes discussions with pharmacy owners considering succession or sale. For more information about our acquisition program and process, please visit or contact our team confidentially. We are committed to seamless transitions that protect your legacy and serve your community. For further information, please contact: Investor Relations info@ Tel: (306) 536-3771 Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-Looking Information: This news release contains 'forward-looking information' regarding the Corporation within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, included herein are forward-looking information. In particular, this news release contains forward-looking information in relation to: the Corporation's continued operational momentum, expanding pharmacy-level contribution, and disciplined progress on the Corporation's national acquisition strategy; the Corporation's coast-to-coast platform and acquisitions ambitions; the Corporation's long-term accretive growth model; the funding available for acquisitions already under letters of intent; the continued appetite from independent pharmacy owners exploring succession; the Corporation's goal of delivering accretive growth; the Corporation's focus on sourcing high-quality pharmacies that align with its long-term acquisition strategy and contribute meaningfully to accretion; the Credit Facilities, including the accordion feature, the impact of the Credit Facilities on the Corporation's acquisition strategy and its acquisition and operating platforms; the Pharmacist Co-Ownership Program including the $5,000,000 credit facility to support the program, the availability of the $5,000,000 credit facility and the terms of this credit facility; the Corporation's work to finalize definitive purchase and sale agreements in furtherance of previously announced letters of intent; the Corporation's expectation to close additional transactions in the second half of the year; and the Corporation's goal to continue to acquire pharmacies as they come to market and to operate such pharmacies under the PharmaChoice Canada banner. This forward-looking information reflects current beliefs and is based on information currently available to the management of the Corporation and on assumptions the Corporation believes are reasonable. These assumptions include, but are not limited to: the completion of previously announce acquisitions; market acceptance of previously announced acquisitions; the continued appetite from independent pharmacy owners exploring succession; market acceptance of the Pharmacist Co-Ownership Program and the terms of the credit facility under such program; the volume of acquisition opportunities presented to the Corporation being equal to or greater than historical volumes; and the continued supply of pharmacies for purchase by the Corporation at prices satisfactory to the Corporation and the ability of the Corporation to acquire such pharmacies. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Corporation to be materially different from those expressed or implied by such forward-looking information. Such risks and other factors may include, but are not limited to: general business, economic, competitive, political and social uncertainties; general capital market conditions and market prices for securities; delay or failure to receive board of directors, third party or regulatory approvals; competition; changes in legislation, including pharmacy regulation, affecting the Corporation; the timing and availability of external financing on acceptable terms; conclusions of economic evaluations and appraisals; and lack of qualified, skilled labour or loss of key individuals. A description of additional risk factors that may cause actual results to differ materially from forward-looking information can be found in the Corporation's disclosure documents on the SEDAR+ website at Although the Corporation has attempted to identify important risks and factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. Readers are cautioned that the foregoing list of factors is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking information as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Forward-looking information contained in this news release is expressly qualified by this cautionary statement. The forward-looking information contained in this news release represents the expectations of the Corporation as of the date of this news release and, accordingly, is subject to change after such date. However, the Corporation expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.
